Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Equillium Inc (EQ)

8.82   -0.15 (-1.67%) 08-13 16:00
Open: 8.82 Pre. Close: 8.97
High: 9.09 Low: 8.62
Volume: 332,818 Market Cap: 170M
Equillium, Inc., a clinical-stage biotechnology company, develops products for autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. Its primary product candidate is itolizumab, a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which is in Phase 1b/2 clinical trials for the treatment of acute graft-versus-host disease; and Phase 1 clinical trial for the treatment of asthma and lupus nephritis. The company was formerly known as Attenuate Biopharmaceuticals, Inc. and changed its name to Equillium, Inc. in May 2017. Equillium, Inc. was founded in 2017 and is headquartered in La Jolla, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 9.094 - 9.155 9.155 - 9.206
Low: 8.506 - 8.564 8.564 - 8.612
Close: 8.734 - 8.829 8.829 - 8.908

Technical analysis

as of: 2020-08-13 4:33:45 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 20.87     One year: 31.59
Support: Support1: 3.02    Support2: 2.51
Resistance: Resistance1: 17.87    Resistance2: 27.05
Pivot: 10.52
Moving Average: MA(5): 9.49     MA(20): 11.23
MA(100): 5.13     MA(250): 4.48
MACD: MACD(12,26): 0.24     Signal(9): 0.82
Stochastic oscillator: %K(14,3): 9.32     %D(3): 10.01
RSI: RSI(14): 46.45
52-week: High: 27.05  Low: 2.20  Change(%): 117.8
Average Vol(K): 3-Month: 271598  10-Days: 68848

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
EQ has closed above bottom band by 15.7%. Bollinger Bands are 2.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 13 Aug 2020
Equillium Announces Pricing of Public Offering of Common Stock - GlobeNewswire

Wed, 12 Aug 2020
Is Equillium Inc (EQ) The Right Choice in Biotechnology? - InvestorsObserver

Wed, 12 Aug 2020
The Unprecedented Rise of Equillium Inc. (NASDAQ:EQ) - The Oracle Dispatch

Wed, 12 Aug 2020
Equillium Reports Second Quarter 2020 Financial Results and Recent Highlights - GlobeNewswire

Tue, 11 Aug 2020
Equillium Inc. (EQ) Quarterly Performance is 212.11%: Here is the Surprise Factor - The InvestChronicle

Tue, 11 Aug 2020
Equillium Inc (EQ) Stock: Is It a Good Pick? - InvestorsObserver

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NasdaqGS
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 18
Shares Float (M) 7
% Held by Insiders 63.33
% Held by Institutions 26.01
Shares Short (K) 11
Shares Short P. Month (K) 76

Stock Financials

EPS -1.580
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 2.060
Profit Margin
Operating Margin
Return on Assets (ttm) -30.9
Return on Equity (ttm) -57.4
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -1.572
Qtrly Earnings Growth
Operating Cash Flow (M) -25
Levered Free Cash Flow (M) -16

Stock Valuations

PE Ratio -5.58
PEG Ratio
Price to Book value 4.28
Price to Sales
Price to Cash Flow -6.27

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.